Skip to main content

The smartphone as a research enabling tool and instrument of patients' well-being

Ad Scientiam was created to allow Research and Clinical studies to leverage new possibilities offered by the usage of smartphones and connected objects.

Accomplished Medical Practitioners and IT professionals, we believe in bridging the gap between health and technology.

Now that Smartphones and connected devices are everyday tools, they can completely change the interaction with the health sector.

Wearables and Research Kit compatibility

The digital revolution is changing the way we live. Communicating is becoming easier. Today, we live in a connected world and new healthcare practices take advantage of "e-health".

Apple's Research Kit represents a significant opportunity for medical research. Connected devices can be used as new investigative tools which are non-invasive, non-stigmatizing and which provide multi-mode data capturing. Ad Scientiam develops solutions which take advantage of those New Information and Communication Technologies.

We have built partnerships in several innovative areas such as smart fabrics industries and connected devices manufacturers. We strongly believe that bringing together a dual medical and technological approach will significantly contribute to research as well as improve patients' well-being. By joining medical experts and IT professionals, Ad Scientiam embodies this goal... Join us!

Discover Adscientiam (video)

The use of ADS Research in order to collect data is shown in the following video. Learn how ADS Research is able to collect data in the "real" world.

Ad Scientiam in the Press

Interview de Ad Scientiam dans entreprenons.fr

created by entreprenons.fr

Découvrez comment Ad Scientiam s’est fait une place dans le monde très fermé de la santé connectée.

Ad Scientiam invited by ROCHE France at "Hello Tomorrow"

created by hello_tomorrow

Hello Tomorrow: "Where science and technology meet entrepreneurship to build our tomorrow". Ad Scientiam is invited by Roche France

Data : big, open, smart… Comment les données en vie réelle impactent le cycle de vie du médicament ?